Showing results (1801-1810 of 3,157) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|May 10, 2021
Loss of H3K27me3 in meningiomasFarshad Nassiri, Justin Z Wang, Olivia Singh, et al.
Neuro-Oncology|April 28, 2021
Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumorsYueli Cui, Chao Li, Zhenhuan Jiang, et al.
Neuro-Oncology|April 28, 2021
Epidemiology of brain metastases and leptomeningeal diseaseNayan Lamba, Patrick Y Wen, Ayal A Aizer
Neuro-Oncology|May 27, 2015
Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United StatesVarun R Kshettry, Quinn T Ostrom, Carol Kruchko, et al.
Neuro-Oncology|May 27, 2015
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastomaElizabeth R Gerstner, Xiaobu Ye, Dan G Duda, et al.
Neuro-Oncology|June 10, 2020
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomasJerrold L Boxerman, Chad C Quarles, Leland S Hu, et al.
Neuro-Oncology|April 30, 2020
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trialCatherine Hanna, Kathreena M Kurian, Karin Williams, et al.
Neuro-Oncology|April 25, 2020
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastomaWen-Bin Yang, Che-Chia Hsu, Tsung-I Hsu, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Pageof 316